Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1

Cited by (1,077)

Items 701–800 of 1,077

1. Why Are Some Properties More Difficult To Predict than Others? A Study of QSPR Models of Solubility, Melting Point, and Log P
   Laura D. Hughes, David Scott Palmer, Florian Nigsch, John B. O. Mitchell · 2008 · Journal of Chemical Information and Modeling
2. Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transporters
   Yakun Chen, Yong Tang, Changxiong Guo, Jiuhui Wang, Debasish Boral, Daotai Nie · 2012 · Biochemical Pharmacology
3. Novel approaches to developing new antibiotics for bacterial infections
   Anthony R. M. Coates, Yanmin Hu · 2007 · British Journal of Pharmacology
4. Getting the most out of PubChem for virtual screening
   Sunghwan Kim · 2016 · Expert Opinion on Drug Discovery
5. Tackling the outer membrane: facilitating compound entry into Gram-negative bacterial pathogens
   Saxena, Deepanshi, Maitra, Rahul, Bormon, Rakhi, Czekanska, Marta, Meiers, Joscha, Titz, Alexander, Verma, Sandeep, Chopra, Sidharth · 2023 · npj Antimicrobials and Resistance
6. Principle and design of pseudo-natural products
   George Karageorgis, Daniel J. Foley, Luca Laraia, Herbert Waldmann · 2020 · Nature Chemistry
7. The use of biopharmaceutic classification of drugs in drug discovery and development: current status and future extension
   Hans Lennernäs, Bertil Abrahamsson · 2005 · Journal of Pharmacy and Pharmacology
8. TargetHunter: An In Silico Target Identification Tool for Predicting Therapeutic Potential of Small Organic Molecules Based on Chemogenomic Database
   Lirong Wang, Chao Ma, Peter Wipf, Haibin Liu, Weiwei Su, Xiang‐Qun Xie · 2013 · The AAPS Journal
9. Pharmacokinetics and drug-likeness of antidiabetic flavonoids: Molecular docking and DFT study
   Mamaru Bitew Alem, Tegene Desalegn, Taye Beyene Demissie, Anteneh Belayneh, Milkyas Endale, Rajalakshmanan Eswaramoorthy · 2021 · PLoS ONE
10. In vitro and in vivo performance of novel supersaturated self-nanoemulsifying drug delivery systems (super-SNEDDS)
    Thomas, N., Holm, R., Müllertz, A., Rades, T. · 2012 · Journal of Controlled Release
11. Bayer’s in silico ADMET platform: a journey of machine learning over the past two decades
    Göller, Andreas H., Kuhnke, Lara, Montanari, Floriane, Bonin, Anne, Schneckener, Sebastian, ter Laak, Antonius, Wichard, Jörg, Lobell, Mario, Hillisch, Alexander · 2020 · Drug Discovery Today
12. Natural products as an inspiration in the diversity-oriented synthesis of bioactive compound libraries
    Christopher Cordier, Daniel Morton, Sarah Murrison, Adam S. Nelson, Catherine O'Leary-Steele · 2008 · Natural Product Reports
13. In Silico Approaches for Predicting ADME Properties of Drugs
    Fumiyoshi Yamashita, Mitsuru Hashida · 2004 · Drug Metabolism and Pharmacokinetics
14. Delivery of Lipophilic Bioactives: Assembly, Disassembly, and Reassembly of Lipid Nanoparticles
    Mingfei Yao, Hang Xiao, David Julian McClements · 2013 · Annual Review of Food Science and Technology
15. Pharmacokinetic and Pharmacodynamic Properties of Drug Delivery Systems
    Patrick M. Glassman, Vladimir R. Muzykantov · 2019 · Journal of Pharmacology and Experimental Therapeutics
16. Transition metal chelators, pro-chelators, and ionophores as small molecule cancer chemotherapeutic agents
    Axel Steinbrueck, Adam C. Sedgwick, James T. Brewster, Kai‐Cheng Yan, Ying Shang, Daniel M. Knoll, Gabriela I. Vargas‐Zúñiga, Xiao‐Peng He, He Tian, Jonathan L. Sessler · 2020 · Chemical Society Reviews
17. High speed electrospinning for scaled-up production of amorphous solid dispersion of itraconazole
    Zsombor Kristóf Nagy, Attila Balogh, Balázs Démuth, Hajnalka Pataki, Tamás Vígh, Bence Szabó, Kolos Molnár, Bence T. Schmidt, Péter Horák, György Marosi et al. · 2015 · International Journal of Pharmaceutics
18. Novel Pieces for the Emerging Picture of Sulfoximines in Drug Discovery: Synthesis and Evaluation of Sulfoximine Analogues of Marketed Drugs and Advanced Clinical Candidates
    Juan Alberto Sirvent, Ulrich Lücking · 2017 · ChemMedChem
19. Progress in Structure Based Drug Design for G Protein-Coupled Receptors
    Miles Congreve, CHRISTOPHER JAMES LANGMEAD, Jonathan S. Mason, Fiona H. Marshall · 2011 · Journal of Medicinal Chemistry
20. Application of Fragment-Based Lead Generation to the Discovery of Novel, Cyclic Amidine β-Secretase Inhibitors with Nanomolar Potency, Cellular Activity, and High Ligand Efficiency
    Philip D. Edwards, Jeffrey S. Albert, Mark A. Sylvester, David Aharony, Donald W. Andisik, Owen Callaghan, James B. Campbell, Robin A. E. Carr, Gianni Chessari, Miles Congreve et al. · 2007 · Journal of Medicinal Chemistry
21. Solubility and Dissolution Profile Assessment in Drug Discovery
    Kiyohiko Sugano, Arimichi Okazaki, Shohei Sugimoto, Sumitra Tavornvipas, Atsushi Omura, Takashi Mano · 2007 · Drug Metabolism and Pharmacokinetics
22. Quantitative structure–activity relationships (QSARs) for the prediction of skin permeation of exogenous chemicals
    Hiren K. Patel, Wil ten Berge, M Cronin · 2002 · Chemosphere
23. Identification of N-phenyl-N′-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4
    Qian Zhao, Liying Ma, Shibo Jiang, Hong Lü, Shuwen Liu, Yuxian He, Nathan Strick, Nouri Neamati, Asim Kumar Debnath · 2005 · Virology
24. Hybrid Drugs—A Strategy for Overcoming Anticancer Drug Resistance?
    Marta Szumilak, Anna Wiktorowska‐Owczarek, Andrzej Stańczak · 2021 · Molecules
25. Lipophilic Permeability Efficiency Reconciles the Opposing Roles of Lipophilicity in Membrane Permeability and Aqueous Solubility
    Matthew R. Naylor, Andrew M. Ly, Mason J. Handford, Daniel P. Ramos, Cameron R. Pye, Akihiro Furukawa, Victoria G. Klein, Ryan P. Noland, Quinn D. Edmondson, Alexandra C. Turmon et al. · 2018 · Journal of Medicinal Chemistry
26. Solubility Challenge: Can You Predict Solubilities of 32 Molecules Using a Database of 100 Reliable Measurements?
    Antonio Llinàs, Robert Charles Glen, Jonathan M. Goodman · 2008 · Journal of Chemical Information and Modeling
27. Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches
    Anuj Kumar, Gourav Choudhir, Sanjeev Kumar Shukla, Mansi Sharma, Pankaj Kumar Tyagi, Arvind Bhushan, Madhu Rathore · 2020 · Journal of Biomolecular Structure and Dynamics
28. Enhanced Oral Bioavailability of a Poorly Water Soluble Drug PNU‐91325 by Supersaturatable Formulations
    Ping Gao, Michael E. Guyton, Tiehua Huang, Juliane M. Bauer, Kevin J. Stefanski, Qun Lu · 2004 · Drug Development and Industrial Pharmacy
29. Computer-aided drug design: the next 20 years
    John H. Van Drie · 2007 · Journal of Computer-Aided Molecular Design
30. ChemGPS-NP: Tuned for Navigation in Biologically Relevant Chemical Space
    Josefin Larsson, Johan Gottfries, Sorel Mureşan, Anders Backlund · 2007 · Journal of Natural Products
31. Structural and conformational determinants of macrocycle cell permeability
    Björn Over, Pär Matsson, Christian Tyrchan, Per Artursson, B.C. Doak, Michael A. Foley, Constanze Hilgendorf, Stephen E. Johnston, Maurice D. Lee, Richard James Lewis et al. · 2016 · Nature Chemical Biology
32. Cryptic binding sites on proteins: definition, detection, and druggability
    Sándor Vajda, Dmitri Beglov, Amanda Wakefield, Megan E. Egbert, Adrian Whitty · 2018 · Current Opinion in Chemical Biology
33. Substructural fragments: an universal language to encode reactions, molecular and supramolecular structures
    Varnek, A., Fourches, D., Hoonakker, F., Solov’ev, V. P. · 2005 · Journal of Computer-Aided Molecular Design
34. Solution Conformations Shed Light on PROTAC Cell Permeability
    Atilaw, Yoseph, Poongavanam, Vasanthanathan, Svensson Nilsson, Caroline, Nguyen, Duy, Giese, Anja, Meibom, Daniel, Erdelyi, Mate, Kihlberg, Jan · 2021 · ACS Medicinal Chemistry Letters
35. Pharmacophore Models and Pharmacophore-Based Virtual Screening: Concepts and Applications Exemplified on Hydroxysteroid Dehydrogenases
    Teresa Kaserer, Katharina R. Beck, Muhammad Akram, Alex Odermatt, Daniela Schuster · 2015 · Molecules
36. Pharmacology beyond the patient – The environmental risks of human drugs
    Lina M. Gunnarsson, Jason Snape, Bas Verbruggen, Stewart F. Owen, Erik Kristiansson, Luigi Margiotta‐Casaluci, Tobias Österlund, Kathryn Hutchinson, Dean Leverett, Becky Marks et al. · 2019 · Environment International
37. Properties of FDA-approved small molecule protein kinase inhibitors: A 2022 update
    Robert Jr. Roskoski · 2021 · Pharmacological Research
38. Medicinal chemistry of target family-directed masterkeys
    Gerhard Müller · 2003 · Drug Discovery Today
39. A family of phosphodiesterase inhibitors discovered by cocrystallography and scaffold-based drug design
    Graeme L. Card, Landy K. Blasdel, Bruce P. England, Chao Zhang, Yoshihisa Suzuki, Sam Gillette, Daniel Fong, Prabha N. Ibrahim, Dean R. Artis, Gideon E. Bollag et al. · 2005 · Nature Biotechnology
40. 1,2,3-Triazole derivatives as antitubercular agents: synthesis, biological evaluation and molecular docking study
    Mubarak Hanif Shaikh, Dnyaneshwar D. Subhedar, Laxman Nawale, Dhiman M. Sarkar, Firoz A. Kalam Khan, Jaiprakash Navnath Sangshetti, Bapurao B. Shingate · 2015 · MedChemComm
41. Molecular properties prediction and synthesis of novel 1,3,4-oxadiazole analogues as potent antimicrobial and antitubercular agents
    Mohamed Jawed Ahsan, Jeyabalan Govinda Samy, Habibullah Khalilullah, Md. Shivli Nomani, Pankaj Saraswat, Ramakant Gaur, Abhimanyu Kumar Singh · 2011 · Bioorganic & Medicinal Chemistry Letters
42. Discovery of a Novel Class of Phosphodiesterase 10A Inhibitors and Identification of Clinical Candidate 2-[4-(1-Methyl-4-pyridin-4-yl-1 H -pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920) for the Treatment of Schizophrenia†Coordinates of the PDE10A crystal structures have been deposited in the Protein Data Bank for compound 1 (3HQW), 2 (3HQY), 3 (3HQW) and 9 (3HR1).
    Patrick R. Verhoest, Douglas S. Chapin, Michael L. Corman, Kari R. Fonseca, John F. Harms, Xinjun Hou, Eric S. Marr, Frank S. Menniti, Frederick Nelson, Rebecca O’Connor et al. · 2009 · Journal of Medicinal Chemistry
43. Evaluation of Dynamic Polar Molecular Surface Area as Predictor of Drug Absorption: Comparison with Other Computational and Experimental Predictors
    Katrin Palm, Kristina Luthman, Anna-Lena B. Ungell, Gert Strandlund, Farideh Beigi, Per Lundahl, Per Artursson · 1998 · Journal of Medicinal Chemistry
44. Elimination of substances from the brain parenchyma: efflux via perivascular pathways and via the blood–brain barrier
    Hladky, Stephen B., Barrand, Margery A. · 2018 · Fluids and Barriers of the CNS
45. Structural insights into inhibition of the bivalent menin-MLL interaction by small molecules in leukemia
    Aibin Shi, Marcelo J. Murai, Shihan He, George Lund, Thomas Hartley, Trupta Purohit, Gireesh Reddy, M. Chruszcz, Jolanta E. Grembecka, Tomasz Cierpicki · 2012 · Blood
46. High-Throughput Screening Identifies Inhibitors of the SARS Coronavirus Main Proteinase
    Jan Blanchard, Nadine H. Elowe, Carly Huitema, Pascal D. Fortin, Jonathan D. Cechetto, Lindsay D. Eltis, Eric D. Brown · 2004 · Chemistry & Biology
47. Molecular Dynamics
    P. Sneha, C. George Priya Doss · 2015 · Advances in protein chemistry and structural biology
48. The discovery of potential acetylcholinesterase inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studies
    Lu, Shin-Hua, Wu, Josephine W, Liu, Hsuan-Liang, Zhao, Jian-Hua, Liu, Kung-Tien, Chuang, Chih-Kuang, Lin, Hsin-Yi, Tsai, Wei-Bor, Ho, Yih · 2011 · Journal of Biomedical Science
49. Nanoscale drug delivery systems and the blood–brain barrier
    Khalin, Igor, Alyautdin, Renad, Ismail, Nafeeza Mohd, Haron, Muhammad Huzaimi, Kuznetsov, Dmitry · 2014 · International Journal of Nanomedicine
50. Application of ALOGPS to predict 1‐octanol/water distribution coefficients, logP, and logD, of AstraZeneca in‐house database
    Igor V. Tetko, Pierre Bruneau · 2004 · Journal of Pharmaceutical Sciences
51. Accelerated computational discovery of high-performance materials for organic photovoltaics by means of cheminformatics
    Roberto Olivares‐Amaya, Carlos Amador‐Bedolla, Johannes Hachmann, Şule Atahan-Evrenk, Roel S. Sánchez‐Carrera, Leslie Vogt-Maranto, Alán Aspuru‐Guzik · 2011 · Energy & Environmental Science
52. Fragments, network biology and designing multiple ligands
    Richard Morphy, Zoran Ranković · 2006 · Drug Discovery Today
53. Measurement of Dissociation Constants (pKa Values) of Organic Compounds by Multiplexed Capillary Electrophoresis Using Aqueous and Cosolvent Buffers**Advanced Analytical Technologies, Inc. (Formerly CombiSep), 2711 South Loop Drive, Suite 4200, Ames, IA 50010.
    Marina Y. Shalaeva, Jeremy R. Kenseth, Franco Lombardo, Andrea Bastin · 2008 · Journal of Pharmaceutical Sciences
54. The solubility–permeability interplay and oral drug formulation design: Two heads are better than one
    Arik Dahan, Avital Beig, David Lindley, Jonathan M. Miller · 2016 · Advanced Drug Delivery Reviews
55. Recognition of Natural Products as Potential Inhibitors of COVID-19 Main Protease (Mpro): In-Silico Evidences
    Rohan R. Narkhede, Ashwini Pise, Rameshwar S. Cheke, Sachin D. Shinde · 2020 · Natural Products and Bioprospecting
56. Discovery of a Dihydroisoquinolinone Derivative (NVP-CGM097): A Highly Potent and Selective MDM2 Inhibitor Undergoing Phase 1 Clinical Trials in p53wt Tumors
    Holzer, Philipp, Masuya, Keiichi, Furet, Pascal, Kallen, Joerg, Valat-Stachyra, Therese, Ferretti, Stéphane, Berghausen, Joerg, Bouisset-Leonard, Michèle, Buschmann, Nicole, Pissot-Soldermann, Carole et al. · 2015 · Journal of Medicinal Chemistry
57. Small Molecule Modulators of Copper-Induced Aβ Aggregation
    Hindo, Sarmad S., Mancino, Allana M., Braymer, Joseph J., Liu, Yihong, Vivekanandan, Subramanian, Ramamoorthy, Ayyalusamy, Lim, Mi Hee · 2009 · Journal of the American Chemical Society
58. What do we know and when do we know it?
    Anthony O. Nicholls · 2008 · Journal of Computer-Aided Molecular Design
59. From fragment to clinical candidate—a historical perspective
    Gianni Chessari, Andrew Woodhead · 2009 · Drug Discovery Today
60. Library Design for Fragment Based Screening
    Ansgar Schuffenhauer, Simon Rüdisser, Andreas L. Marzinzik, Wolfgang Jahnke, Paul M. Selzer, Edgar Jacoby · 2005 · Current Topics in Medicinal Chemistry
61. Promiscuous Aggregate-Based Inhibitors Promote Enzyme Unfolding
    Kristin E. D. Coan, David A. Maltby, Alma L. Burlingame, Brian K. Shoichet · 2009 · Journal of Medicinal Chemistry
62. Machine Learning-based Virtual Screening and Its Applications to Alzheimer’s Drug Discovery: A Review
    Kristy A. Carpenter, Xudong Huang · 2018 · Current Pharmaceutical Design
63. Bifunctional Compounds for Controlling Metal-Mediated Aggregation of the Aβ₄₂Peptide
    Sharma, Anuj K., Pavlova, Stephanie T., Kim, Jaekwang, Finkelstein, Darren, Hawco, Nicholas J., Rath, Nigam P., Kim, Jungsu, Mirica, Liviu M. · 2012 · Journal of the American Chemical Society
64. The Rule of Five for Non-Oral Routes of Drug Delivery: Ophthalmic, Inhalation and Transdermal
    Young Bin Choy, Mark R. Prausnitz · 2010 · Pharmaceutical Research
65. Solubility Advantage of Amorphous Pharmaceuticals: II. Application of Quantitative Thermodynamic Relationships for Prediction of Solubility Enhancement in Structurally Diverse Insoluble Pharmaceuticals
    Sharad B. Murdande, Michael Jon Pikal, Ravi M. Shanker, Robin H. Bogner · 2010 · Pharmaceutical Research
66. Alzheimer's disease drug development and the problem of the blood‐brain barrier
    William M. Pardridge · 2009 · Alzheimer s & Dementia
67. Discovery of 4-Benzoyl-1-[(4-methoxy-1H- pyrrolo[2,3-b]pyridin-3-yl)oxoacetyl]-2- (R)-methylpiperazine (BMS-378806): A Novel HIV-1 Attachment Inhibitor That Interferes with CD4-gp120 Interactions
    Tao Wang, Zhongxing Zhang, Owen B. Wallace, Milind Deshpande, Haiquan Fang, Zheng Yang, Lisa M. Zadjura, Donald L. Tweedie, Xiaohua Stella Huang, Fang Zhao et al. · 2003 · Journal of Medicinal Chemistry
68. PKIDB: A Curated, Annotated and Updated Database of Protein Kinase Inhibitors in Clinical Trials
    Fabrice Carles, Stéphane Bourg, Christophe Meyer, Pascal Bonnet · 2018 · Molecules
69. Selective Optimization of Side Activities: Another Way for Drug Discovery
    Camille Georges Wermuth · 2004 · Journal of Medicinal Chemistry
70. Impact of non-proteinogenic amino acids in the discovery and development of peptide therapeutics
    Ding, Yun, Ting, Joey Paolo, Liu, Jinsha, Al-Azzam, Shams, Pandya, Priyanka, Afshar, Sepideh · 2020 · Amino Acids
71. Designing novel building blocks is an overlooked strategy to improve compound quality
    Frederick W. Goldberg, Jason G. Kettle, Thierry Kogej, Matthew W. D. Perry, Nick P. Tomkinson · 2014 · Drug Discovery Today
72. Spontaneous Membrane-Translocating Peptides by Orthogonal High-Throughput Screening
    Jessica R. Marks, Jesse K. Placone, Kalina A. Hristova, William C. Wimley · 2011 · Journal of the American Chemical Society
73. Nasal Drug Delivery in Humans
    Christoph Bitter, Katja Suter, Christian Surber · 2011 · Current problems in dermatology
74. Bacteriophages and phage-inspired nanocarriers for targeted delivery of therapeutic cargos
    Mahdi Karimi, Hamed Mirshekari, Seyed Masoud Moosavi Basri, Sajad Bahrami, Mohsen Moghoofei, Michael Richard Hamblin · 2016 · Advanced Drug Delivery Reviews
75. Prey for the Proteasome: Targeted Protein Degradation—A Medicinal Chemist's Perspective
    Laura Martina Luh, Ulrike Scheib, Katrin Juenemann, Lars Wortmann, Michael Brands, Philipp M. Cromm · 2020 · Angewandte Chemie International Edition
76. Drug permeability profiling using cell-free permeation tools: overview and applications
    Berben, Philippe, Bauer-Brandl, Annette, Brandl, Martin, Faller, Bernard, Flaten, Gøril Eide, Jacobsen, Ann-Christin, Brouwers, Joachim, Augustijns, Patrick · 2018 · European Journal of Pharmaceutical Sciences
77. Modeling biophysical and biological properties from the characteristics of the molecular electron density, electron localization and delocalization matrices, and the electrostatic potential
    Cherif Farid Matta · 2014 · Journal of Computational Chemistry
78. Structure−Activity Relationship Study of Betulinic Acid, A Novel and Selective TGR5 Agonist, and Its Synthetic Derivatives: Potential Impact in Diabetes
    Cédric Genet, Axelle Strehle, Céline Schmidt, Geoffrey Boudjelal, Annelise Lobstein, Kristina Schoonjans, Michel Souchet, Johan H. Auwerx, Régis Saladin, Alain Wagner · 2009 · Journal of Medicinal Chemistry
79. Drug Liposome Partitioning as a Tool for the Prediction of Human Passive Intestinal Absorption
    K. Balon, Bernd U. Riebesehl, Bernhard W. Müller · 1999 · Pharmaceutical Research
80. sc-PDB: an Annotated Database of Druggable Binding Sites from the Protein Data Bank
    Esther Kellenberger, Pascal Müller, Claire Schalon, Guillaume Bret, Nicolas Foata, Didier Rognan · 2006 · Journal of Chemical Information and Modeling
81. Form and Function in Cyclic Peptide Natural Products: A Pharmacokinetic Perspective
    Andrew T. Bockus, Cayla M. McEwen, R. Scott Lokey · 2013 · Current Topics in Medicinal Chemistry
82. Strategies for formulating and delivering poorly water-soluble drugs
    Marta Rodriguez-Aller, Davy Guillarme, Jean‐Luc Veuthey, Robert Gurny · 2015 · Journal of Drug Delivery Science and Technology
83. Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging
    Victor William Pike · 2016 · Current Medicinal Chemistry
84. Non-invasive drug delivery technology: development and current status of transdermal drug delivery devices, techniques and biomedical applications
    Naseem Akhtar, Varsha Singh, Mohammad Yusuf, Riaz A. Khan · 2020 · Biomedizinische Technik/Biomedical Engineering
85. Polymeric micelles of biodegradable diblock copolymers: enhanced encapsulation of hydrophobic drugs
    Hussein, Yasser H. A., Youssry, Mohamed · 2018 · Materials
86. Toxicology Strategies for Drug Discovery: Present and Future
    Eric A.G. Blomme, Yvonne Will · 2015 · Chemical Research in Toxicology
87. Protein-protein interaction modulators: advances, successes and remaining challenges
    Lloyd Mabonga, Abidemi Paul Kappo · 2019 · Biophysical Reviews
88. Classification of Cytochrome P450 Inhibitors and Noninhibitors Using Combined Classifiers
    Feixiong Cheng, Yue Yu, Jie Shen, Lei Yang, Weihua Li, Guixia Liu, Philip W. Lee, Yun Tang · 2011 · Journal of Chemical Information and Modeling
89. Experimental and Computational Screening Models for Prediction of Aqueous Drug Solubility
    Christel A. S. Bergström, Ulf Norinder, Kristina Luthman, Per Artursson · 2002 · Pharmaceutical Research
90. Histamine H3 Receptor Antagonists Go to Clinics
    Kerstin Sander, Tim Kottke, Holger Stark · 2008 · Biological and Pharmaceutical Bulletin
91. Dissolution Improvement and the Mechanism of the Improvement from Cocrystallization of Poorly Water-soluble Compounds
    Koji Shiraki, Noriyuki Takata, Ryusuke Takano, Yoshiki Hayashi, Katsuhide Terada · 2008 · Pharmaceutical Research
92. Towards Robot Scientists for autonomous scientific discovery
    Andrew Sparkes, Wayne Aubrey, E Byrne, Amanda J. Clare, M. N. A. Khan, Maria Liakata, Magdalena Markham, Jem J. Rowland, Larisa Soldatova, Kenneth E. Whelan et al. · 2010 · Automated Experimentation
93. Use of a Dynamic in Vitro Lipolysis Model to Rationalize Oral Formulation Development for Poor Water Soluble Drugs: Correlation with in Vivo Data and the Relationship to Intra-Enterocyte Processes in Rats
    Arik Dahan, Amnon Hoffman · 2006 · Pharmaceutical Research
94. Development of a Purine-Scaffold Novel Class of Hsp90 Binders that Inhibit the Proliferation of Cancer Cells and Induce the Degradation of Her2 Tyrosine Kinase
    Gabriela Chiosis, Brian S. Lucas, Alexander Albertovich Shtil, Henri Huezo, Neal X. Rosen · 2002 · Bioorganic & Medicinal Chemistry
95. Cyclic Peptides as Drugs for Intracellular Targets: The Next Frontier in Peptide Therapeutic Development
    Laura K. Buckton, Marwa Nadia Rahimi, Shelli R. McAlpine · 2020 · Chemistry - A European Journal
96. Modeling the expansion of virtual screening libraries
    Lyu, Jiankun, Irwin, John J., Shoichet, Brian K. · 2023 · Nature Chemical Biology
97. Current trends in lead discovery: Are we looking for the appropriate properties?
    Tudor Ionel Oprea · 2002 · Journal of Computer-Aided Molecular Design
98. Predicting aqueous solubility from structure
    John S. Delaney · 2005 · Drug Discovery Today
99. Calculating Partition Coefficients of Small Molecules in Octanol/Water and Cyclohexane/Water
    Caitlin C. Bannan, Gaetano Calabrò, Daisy Y. Kyu, David L. Mobley · 2016 · Journal of Chemical Theory and Computation
100. A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment
     Da Wang, Chao Wang, Liang Wang, Yue Chen · 2019 · Drug Delivery